MedLife S.A.

Regulatory Filings • Apr 5, 2024

To: BUCHAREST STOCK EXCHANGE FINANCIAL SUPERVISORY AUTHORITY

CURRENT REPORT

Current report drafted according to the stipulations of ASF Regulation no. 5/2018 on issuers of financial instruments and market operations, Law no. 24/2017 on issuers of financial instruments and market operations, and the provisions of Article 99 of the Bucharest Stock Exchange Code, Title II, Issuers and Financial Instruments

Report Date: 5 April 2024

Name of the issuing company: MED LIFE S.A. ("MedLife" or "the Company") Registered Office: Bucharest, Calea Grivitei, no. 365, district 1, Romania

Telephone / Fax number: 0374 180 470

Unique Registration Code at the National Office of Trade Registry: 8422035

Order number on the Trade Registry: J40/3709/1996

Subscribed and paid-in share capital: 132,870,492 RON

Total number of shares: 531,481,968 (out of which 292,042 shares without voting rights and 531,189,926 shares with voting rights)

Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category

Significant events to report:

Closed trading period: 10 April – 9 May 2024

MED LIFE S.A. informs investors that between 10 April and 9 May 2024, the persons who have access to privileged information ("insiders") according to the provisions of FSA Regulation no. 5/2018, Law no. 24/2017 and EU Regulations no. 522/2016 and no. 596/2014 respectively, do not have the right to carry out any transactions in their own name or on behalf of a third party, directly or indirectly, related to shares, bonds, securities, debt or other derivative financial instruments of the Company.

This closed trading period occures as a result of the fact that on 10 May 2024, the Company will publish the 2024 First Quarter Report.

Mihail Marcu Chief Executive Officer

______________